Glutathione, iron and Parkinson’s disease
- 30 September 2002
- journal article
- review article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 64 (5-6), 1037-1048
- https://doi.org/10.1016/s0006-2952(02)01174-7
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation?Journal of Chemical Neuroanatomy, 2000
- Deoletion of brain glutathione is accompanied by impaired micochondrial function and decreased N-acetyl aspartate concentrationNeurochemical Research, 1995
- Increased Intra‐ and Extracellular Concentrations of γ‐Glutamylglutamate and Related Dipeptides in the Ischemic Rat Striatum: Involvement of γ‐Glutamyl TranspeptidaseJournal of Neurochemistry, 1994
- Glutathione depletion and formation of glutathione-protein mixed disulfide following exposure of brain mitochondria to oxidative stressBiochemical and Biophysical Research Communications, 1990
- Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainJournal of Neural Transmission, 1988
- Chemically induced Parkinson's disease: Intermediates in the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4-phenyl-pyridinium ionBiochemical and Biophysical Research Communications, 1987
- Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patientsNeuroscience Letters, 1986
- Formation of superoxide and hydroxyl radicals from 1-methyl-4-phenylpyridinium ion(MPP+): Reductive activation by NADPH cytochrome P-450 reductaseBiochemical and Biophysical Research Communications, 1986
- The importance of free radicals and catalytic metal ions in human diseasesMolecular Aspects of Medicine, 1985
- Possible role of neuromelanin in the pathogenesis of Parkinson's diseaseMechanisms of Ageing and Development, 1983